New Clinical trial started:MYL-1402O-3001 : at Multicentre in the first line treatment of Patient with Stage IV Non-Squamous Non-Small Cell Lung Cancer
(10-March-2017)
New Clinical trial started:MYL-1402O-3001 :Multicentre, Double-Blind, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of MYL-1402O Compared With Avastin®, in the First -line treatment of Patient with Stage IV Non-Squamous Non-Small Cell Lung Cancer under Dr Naresh Somani